MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.

Journal of Biological Chemistry - United States
doi 10.1074/jbc.a116.806041
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

MicroRNA-221/222 Confers Breast Cancer Fulvestrant Resistance by Regulating Multiple Signaling Pathways

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

Roles of microRNA-221/222 in Type 2 Diabetic Patients With Post-Menopausal Breast Cancer

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

Growth Factor-Induced Resistance to Tamoxifen Is Associated With a Mutation of Estrogen Receptor Α and Its Phosphorylation at Serine 305

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Gap Junction Β‑2 Expression Is Negatively Associated With the Estrogen Receptor Status in Breast Cancer Tissues and Is a Regulator of Breast Tumorigenesis

Oncology Reports
MedicineCancer ResearchOncology
2018English

Sphingosine Kinase 1 Activation by Estrogen Receptor Α36 Contributes to Tamoxifen Resistance in Breast Cancer

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2018English

Twist Contributes to Hormone Resistance in Breast Cancer by Downregulating Estrogen Receptor-Α

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy